Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Cannabigerol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 596Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lygos Completes Commercial-Scale Fermentation Campaign of Bio-based Cannabinoids
    Lygos Completes Commercial-Scale Fermentation Campaign of Bio-based Cannabinoids

    27 Oct 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211027005178/en

    BUSINESSWIRE
    27 Oct 2021
    Share Share
    Cronos Group and Ginkgo Bioworks Announce Achievement of Equity Milestone
    Cronos Group and Ginkgo Bioworks Announce Achievement of Equity Milestone

    23 Aug 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/08/23/2284750/0/en/Cronos-Group-and-Ginkgo-Bioworks-Announce-Achievement-of-Equity-Milestone-in-Partnership-to-Produce-Cultured-Cannabinoids.html

    GLOBENEWSWIRE
    23 Aug 2021
    Share Share
    International Multi-Centre Collaboration Reveals that Cannabigerol
    International Multi-Centre Collaboration Reveals that Cannabigerol

    22 Jun 2018

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/international-multi-centre-collaboration-reveals-that-cannabigerol-acts-directly-on-cannabinoid-receptors-cb1-and-cb2-300671024.html

    PR NEWSWIRE
    22 Jun 2018
    Share Share